4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-037366
Director acquired 8,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fust Matthew K Director | 2020-06-16 | Grant or award | +8,000 | 33,854 | D | ||
| Derivatives | |||||||
| Fust Matthew K Director | 2020-06-16 | Grant or award · Non-Qualified Stock Option (Right to Buy) | +24,500 | 24,500 | D | ||
Loading xslF345X03/doc4.xml…